BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, ...
Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer. ESR1 ...
National Cancer Institute/Unsplash An estimated 170,000 Australians were diagnosed with cancer in 2025.Authors Sarah Diepstraten Senior Research ...
Robert J. DeBernardo, MD, discusses how understanding and treatment of endometrial cancer have evolved dramatically, allowing for more personalized care that directly benefits patients. Instead of a ...
Early menopause is more than just an end to menstruation before the age of 45—it could be a genetic signpost for heightened breast cancer risks. Kirtly Jones, MD, talks to endocrinologist Corinne Welt ...
Survey findings highlight need for improved education and access to precision medicine in the Japanese American ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about understanding Gleason Score and prostate cancer risk. A Gleason score is a ...
Also known as metastatic breast cancer (mBC), Stage IV means the disease has spread to other parts of the body, and approximately 1 in 3 people with breast cancer develop mBC.³ In Lynn’s case, her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results